Ibuprofen B. Braun (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins. Lower prostaglandin levels decrease peripheral nerve sensitization, lower the hypothalamic temperature set‑point, and limit inflammatory fluid accumulation.

The specific dose and infusion rate of Ibuprofen B. Braun are determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal or hepatic function. The product label provides guidance, but the final regimen is individualized.

Safety data for intravenous ibuprofen in pregnancy and lactation are limited. Clinicians should weigh potential benefits against risks, especially in the third trimester, and consider alternative therapies when possible. Breastfeeding mothers should consult a healthcare professional before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Compared with other IV NSAIDs, ibuprofen offers a well‑characterized safety profile and effective analgesia for mild to moderate pain. Unlike opioid analgesics, it does not cause respiratory depression, but it shares class‑related risks such as renal impairment and gastrointestinal bleeding, which must be monitored.

Ibuprofen B. Braun should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture, and extreme temperature fluctuations to maintain stability.

The product is supplied as a sterile intravenous solution. It is administered by a qualified healthcare professional through an IV line, typically as a slow infusion over several minutes, following the dosing instructions provided by the prescriber.

Serious risks include gastrointestinal bleeding or ulceration, acute kidney injury, severe hypersensitivity reactions such as anaphylaxis, and cardiovascular events like hypertension or thrombotic complications, particularly in patients with pre‑existing risk factors.

Patients with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal bleeding, severe renal or hepatic impairment, uncontrolled hypertension, or those receiving anticoagulant therapy without close monitoring should generally avoid this medication.